Interpretation of immunoblots for Lyme borreliosis using a semiquantitative approach

Clinical Microbiology and Infection

Volumn 4, Issue 4, 1998, Pages 205-212

  Ryffel, Karine ^a   Péter, Olivier ^a   Binet, Luc ^b   Dayer, Eric ^a  

^a Institut Central des Hopitaux Valaisans   (Switzerland)

^b Labodia SA   (Switzerland)

Author keywords

Acrodermatitis; Arthritis; Borrelia garinii; Erythema migrans; Immunoblots; Lyme borreliosis; Neuroborreliosis; Sensitivity; Specificity

Indexed keywords

BACTERIUM ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ANTIBODY TITER; ARTICLE; BORRELIA BURGDORFERI; BORRELIA GARINII; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSS REACTION; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HUMAN; IMMUNE RESPONSE; IMMUNOBLOTTING; LYME DISEASE; MAJOR CLINICAL STUDY; PERFORMANCE; PRIORITY JOURNAL; SCORING SYSTEM; SERODIAGNOSIS;

BACTERIA (MICROORGANISMS); BORRELIA; BORRELIA BURGDORFERI; BORRELIA GARINII;

EID: 0031925097     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-0691.1998.tb00670.x     Document Type: Article

References (30)

1. Baranton G, Postic D, Saint Girons I, et al. Delineation of Borrelia burgdorferi sensu stricto, Borrelia garinii sp. nov., and group VS461 associated with Lyme borreliosis. Int J Syst Bacteriol 1992; 42: 378-83.
2. Canica MM, Nato F, du Merle L, Mazie JC, Baranton G, Postic D. Monoclonal antibodies for identification of Borrelia afzelii sp, nov. associated with late cutaneous manifestations of Lyme borreliosis. Scand J Infect Dis 1993; 25: 441-8.
3. Hu CM, Leuba-Garcia S, Kramer MD, Aeschlimann A, Gern L. Comparison in the immunological properties of Borrelia burgdorferi isolates from Ixodes ricinus derived from three endemic areas in Switzerland. Epidemiol Infect 1994; 112: 533-42.
4. Péter O, Bretz AG, Bee D. Occurrence of different genospecies of Borrelia burgdorferi sensu lato in ixodid ticks of Valais, Switzerland. Eur J Epidemiol 1995; 11: 463-7.
5. van Dam AP, Kuiper H, Vos K, et al. Different genospecies of Borrelia burgdorferi are associated with distinct clinical manifestations of Lyme borreliosis. Clin Infect Dis 1993; 17: 708-17.
6. Steere AC. Lyme disease. N Engl J Med 1989; 321: 586-96.
7. Altpeter ES, Meier C. Epidemiologische Aspekte der neurologischen Komplikationen der Lyme-Borreliose in der Schweiz. Schweiz Med Wochenschr 1992; 122: 22-6.
8. Assous MV, Postic D, Paul G, Nevot P, Baranton G. Western blot analysis of sera from Lyme borrehosis patients according to the genomic species of the Borrelia strains used as antigens. Eur J Clin Microbiol Infect Dis 1993, 12: 261-8.
9. Péter O, Bretz A-G, Postic D, Dayer E. Association of distinct species of Borrelia burgdorferi sensu lato with neuroborreliosis in Switzerland. Clin Microbiol Infect 1997; 3: 423-31.
10. Balmelli T, Piffaretti JC. Association between different clinical manifestations of Lyme disease and different species of Borrelia burgdorferi sensu lato Res Microbiol 1995; 146: 329-40.
11. Eiffert H, Ohlenbusch A, Christen HJ, Thomssen R, Spielman A, Matuschka FR Nondifferentiation between Lyme disease spirochetes from vector ticks and human cerebrospinal fluid. J Infect Dis 1995; 171: 476-9.
12. Wilske B, Busch U, Eiffert H, et al. Diversity of OspA and OspC among cerebrospinal fluid isolates of Borrelia burgdorferi sensu lato from patients with neuroborreliosis in Germany. Med Microbiol Immunol (Berl) 1996; 184: 195-201.
13. Lebech AM, Clemmensen O, Hansen K, Comparison of in vitro culture, immunohistochemical staining, and PCR for detection of Borrelia burgdorfen in tissue from experimentally infected animals. J Clin Microbiol 1995; 33: 2328-33.
14. Schmidt BL. PCR. in laboratory diagnosis of human Borrelia burgdorferi infections. Clin Microbiol Rev 1997; 10: 185-201.
15. Bruckbauer HR, Preac-Mursic V. Fuchs R, Wilske B. Cross-reactive proteins of Borrelia burgdorferi. Eur J Clin Microbiol Infect Dis 1992; 11: 224-32.
16. Engstrom SM, Shoop E, Johnson RC. Immunoblot interpretation criteria for serodiagnosis of early Lyme disease. J Clin Microbiol 1995; 33: 419-27
17. Hauser U, Lehnert G, Lobentanzer R, Wilske B, Interpretation criteria for standardized Western blots for three European species of Borrelia burgdorferi sensu lato. J Clin Microbiol 1997; 35: 1433-44.
18. Stanek G, O'Connell S, Cimmino M, et al. European Union Concerted Action on Risk Assessment in Lyme Borreliosis: clinical case definitions for Lyme borreliosis. Wien Klin Wochenschr 1996; 108: 741-7.
19. Wilske B, Fingerle V, Herzer P, et al. Recombinant immunoblot in the serodiagnosis of Lyme borreliosis. Comparison with indirect immunofluorescence and enzymelinked immunosorbent assay. Med Microbiol Immunol (Berl) 1993; 182: 255-70.
20. Zöller L, Burkard S, Schafer H. Validity of western immunoblot band patterns in the serodiagnosis of Lyme borreliosis. J Clin Microbiol 1991; 29: 174-82.
21. Norman GL, Antig JM, Bigaignon G, Hogrefe WR. Serodiagnosis of Lyme borreliosis by Borrelia burgdorferi sensu stricto, B garinii, and B. afzelii -western blots (immunoblots). J Clin Microbiol 1996; 34: 1732-8.
22. Péter O, Marini M, Blanc E, Dupais G. Le diagnostic de la borréliose de Lyme. Schweiz Med Wochenschr 1991; 121: 189-93.
23. Péter O, Bretz AG. Polymorphism of outer surface proteins of Borrelia burgdorferi as a tool for classification. Zentralbl Bakteriol 1992; 277: 28-33.
24. Aeschlimann A, Chamot E, Gigon F, Jeanneret JP, Kesseler D, Walther C. B. burgdorferi in Switzerland. Zentralbl Bakteriol Mikrobiol Hyg [A] 1987; 263: 450-8.
25. Satz N, Ackermann R, Gern L, Aeschlimann A, Ott A, Knoblauch M. Zur Epidemiologie der Infektion, mit Borrelia burgdorferi. Schweiz Med Wochenschr 1988; 118: 422-6.
26. Dressler F, Whalen JA, Reinhardt BN, Steere AC. Western blotting in the serodiagnosis of Lyme disease. J Infect Dis 1993; 167. 392-400.
27. Aguero-Rosenfeld ME, Nowakowski J, McKenna DF, Carbonaro CA. Wormser GP. Serodiagnosis in early Lyme disease [published erratum appears in J Clin Microbiol 1994; 32(3): 860]. J Clin Microbiol 1993; 31: 3090-5.
28. Kalish RA, Leong JM, Steere AC. Early and late antibody responses to full-length and truncated constructs of outer surface protein A of Borrelia burgdorferi in Lyme disease. Infect Immun 1995; 63: 2228-35.
29. Simpson WJ, Schrumpf ME, Schwan TG. Reactivity of human Lyme borrehosis sera with a 39-kilodalton antigen specific to Borrelia burgdorferi. J Clin Microbiol 1990; 28: 1329-37.
30. Wilske B, Preac-Mursic V, Schierz G, Busch KV. Immunochemical and immunological analysis of European Borrelia burgdorferi strains. Zentralbl Bakteriol Mikrobiol Hyg [A] 1986; 263: 92-102